OKLO
Three approvals, one very loud message
Oklo is out here collecting regulatory milestones like they’re Pokemon cards. The headline win: its subsidiary Atomic Alchemy landed the company’s first NRC materials license, which lets it handle, process, and distribute isotopes out of its Idaho Radiochemistry Laboratory.
Why this matters
That’s not just bureaucratic ink on paper. It helps Oklo build out a domestic isotope supply chain, which could matter for everything from healthcare to advanced manufacturing. In other words, this is the kind of permission slip that turns “cool idea” into “actual business.”
Idaho and Texas got their turns too
The company also said the DOE approved the Nuclear Safety Design Agreement for its Aurora powerhouse project at Idaho National Laboratory. That pushes Oklo farther down the road toward its first fast-fission reactor, with the next stop being more safety-analysis review.
And because one approval apparently wasn’t enough, DOE also cleared the NSDA for Atomic Alchemy’s Groves Isotopes Test Reactor in Texas. That project is meant to ramp isotope production at pilot scale, which gives Oklo another lane to monetize beyond just power generation.
Big picture
If you’re an investor, the takeaway is simple: regulators didn’t just blink at Oklo — they opened a few doors. The company still has plenty of execution ahead, but every approval like this makes its commercialization story look a little less like a moonshot and a little more like a roadmap.